Preclinical pharmacokinetic analysis of armillarisin succinate ester in mouse plasma and tissues by LC-MS/MS

Biomed Chromatogr. 2013 Jan;27(1):130-6. doi: 10.1002/bmc.2762. Epub 2012 Jun 5.

Abstract

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed and validated to determine the concentration of armillarisin succinate ester in mouse plasma and tissues, used for preclinical evaluation. Bavachin was employed as the internal standard. Separation was performed on a 3.5 µm Zorbax SB-C(18) column (30 × 2.1 mm), with a mobile phase consisting of methanol and aqueous 20 mm ammonium acetate. Both analyte and internal standard were determined using electrospray ionization and the MS data acquisition was via selected ion monitoring in negative scanning mode. Quantification was performed using the transitions m/z 333 → 233 and 323 → 221 for armillarisin succinate ester and internal standard, respectively. The method was validated with respect to linearity, accuracy, precision, recovery and stability. This assay has been successfully applied to a pharmacokinetic and tissue distribution study after intravenous injection of ASE in mouse in a dose of 10 mg/kg.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzopyrans / analysis
  • Benzopyrans / blood
  • Benzopyrans / chemistry
  • Benzopyrans / pharmacokinetics*
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Esters / analysis
  • Esters / blood
  • Esters / chemistry
  • Esters / pharmacokinetics
  • Female
  • Linear Models
  • Male
  • Mice
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Succinic Acid / analysis
  • Succinic Acid / blood
  • Succinic Acid / chemistry
  • Succinic Acid / pharmacokinetics
  • Tandem Mass Spectrometry / methods*
  • Tissue Distribution

Substances

  • Benzopyrans
  • Esters
  • Succinic Acid
  • armillarisin A